Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 2

Conditions

Motor Activity 3Fatigue 3Breast Neoplasms 2Rectal Neoplasms 1Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Asthenia 1Arthralgia 1

Interventions

Trastuzumab 597Paclitaxel 562Cyclophosphamide 545Docetaxel 479Capecitabine 388Letrozole 350Fulvestrant 311Doxorubicin 285Carboplatin 277Tamoxifen 257Anastrozole 219exemestane 211Epirubicin 210Radiotherapy 197Bevacizumab 189pertuzumab 177Gemcitabine 163Vinorelbine 162pembrolizumab 161Lapatinib 161palbociclib 152Exercise 132Fluorouracil 118Albumin-Bound Paclitaxel 116eribulin 108Magnetic Resonance Spectroscopy 108130-nm albumin-bound paclitaxel 107Everolimus 103Taxes 96Cisplatin 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Breast Neoplasms × methyl hydroxyethyl cellulose × Clear all
NCT02682836 2022-01-06

Physical Activity to Maintain Quality of Life and Physical Function in Women With Metastatic Breast Cancer: a Pilot Study

UNC Lineberger Comprehensive Cancer Center

Phase NA Completed
60 enrolled
Breast

Breast Neoplasms, Fatigue, Motor Activity

NCT01900418 2016-08-08

Physical Activity to Reduce Joint Pain During Aromatase Inhibitor Therapy

University of North Carolina, Chapel Hill

Phase NA Completed
78 enrolled
Breast

Breast Neoplasms, Motor Activity, Arthralgia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡